Cargando…
Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study
OBJECTIVES: To understand the challenges faced by patients with tuberculosis (TB) and factors that influence TB treatment adherence in Ukraine. DESIGN: Qualitative study. SETTING: TB treatment facilities in Kyiv Oblast, Ukraine. PARTICIPANTS: Sixty adults who had undergone treatment for drug-sensiti...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044979/ https://www.ncbi.nlm.nih.gov/pubmed/32014870 http://dx.doi.org/10.1136/bmjopen-2019-032027 |
_version_ | 1783501683634995200 |
---|---|
author | Aibana, Omowunmi Dauria, Emily Kiriazova, Tetiana Makarenko, Olena Bachmaha, Mariya Rybak, Natasha Flanigan, Timothy Palen Petrenko, Vasyl Becker, Anne E Murray, Megan B |
author_facet | Aibana, Omowunmi Dauria, Emily Kiriazova, Tetiana Makarenko, Olena Bachmaha, Mariya Rybak, Natasha Flanigan, Timothy Palen Petrenko, Vasyl Becker, Anne E Murray, Megan B |
author_sort | Aibana, Omowunmi |
collection | PubMed |
description | OBJECTIVES: To understand the challenges faced by patients with tuberculosis (TB) and factors that influence TB treatment adherence in Ukraine. DESIGN: Qualitative study. SETTING: TB treatment facilities in Kyiv Oblast, Ukraine. PARTICIPANTS: Sixty adults who had undergone treatment for drug-sensitive TB between June 2012 and August 2015. METHODS: We conducted semistructured, in-depth, individual interviews among a purposively selected clinical sample of patients previously treated for drug-sensitive TB. Interview content encompassed WHO’s framework for barriers to adherence to long-term therapies and included questions about patient preferences and motivators concerning treatment adherence. We examined treatment experience across strata defined by previously identified risk correlates of non-adherence. RESULTS: Among 60 participants, 19 (32.8%) were HIV positive, 12 (20.3%) had substance use disorder and 9 (15.0%) had not completed TB treatment. Respondents discussed the psychological distress associated with hospital-based TB care, as well as perceived unsupportive, antagonistic interactions with TB providers as major challenges to treatment adherence. An additional barrier to successful treatment completion included the financial toll of lost income during TB treatment, which was exacerbated by the additional costs of ancillary medications and transportation to ambulatory TB clinics. The high pill burden of TB treatment also undermined adherence. These challenges were endorsed among participants with and without major risk factors for non-adherence. CONCLUSIONS: Our findings highlight important barriers to TB treatment adherence in this study population and suggest specific interventions that may be beneficial in mitigating high rates of poor treatment outcomes for TB in Ukraine. |
format | Online Article Text |
id | pubmed-7044979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-70449792020-03-09 Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study Aibana, Omowunmi Dauria, Emily Kiriazova, Tetiana Makarenko, Olena Bachmaha, Mariya Rybak, Natasha Flanigan, Timothy Palen Petrenko, Vasyl Becker, Anne E Murray, Megan B BMJ Open Global Health OBJECTIVES: To understand the challenges faced by patients with tuberculosis (TB) and factors that influence TB treatment adherence in Ukraine. DESIGN: Qualitative study. SETTING: TB treatment facilities in Kyiv Oblast, Ukraine. PARTICIPANTS: Sixty adults who had undergone treatment for drug-sensitive TB between June 2012 and August 2015. METHODS: We conducted semistructured, in-depth, individual interviews among a purposively selected clinical sample of patients previously treated for drug-sensitive TB. Interview content encompassed WHO’s framework for barriers to adherence to long-term therapies and included questions about patient preferences and motivators concerning treatment adherence. We examined treatment experience across strata defined by previously identified risk correlates of non-adherence. RESULTS: Among 60 participants, 19 (32.8%) were HIV positive, 12 (20.3%) had substance use disorder and 9 (15.0%) had not completed TB treatment. Respondents discussed the psychological distress associated with hospital-based TB care, as well as perceived unsupportive, antagonistic interactions with TB providers as major challenges to treatment adherence. An additional barrier to successful treatment completion included the financial toll of lost income during TB treatment, which was exacerbated by the additional costs of ancillary medications and transportation to ambulatory TB clinics. The high pill burden of TB treatment also undermined adherence. These challenges were endorsed among participants with and without major risk factors for non-adherence. CONCLUSIONS: Our findings highlight important barriers to TB treatment adherence in this study population and suggest specific interventions that may be beneficial in mitigating high rates of poor treatment outcomes for TB in Ukraine. BMJ Publishing Group 2020-02-02 /pmc/articles/PMC7044979/ /pubmed/32014870 http://dx.doi.org/10.1136/bmjopen-2019-032027 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Global Health Aibana, Omowunmi Dauria, Emily Kiriazova, Tetiana Makarenko, Olena Bachmaha, Mariya Rybak, Natasha Flanigan, Timothy Palen Petrenko, Vasyl Becker, Anne E Murray, Megan B Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study |
title | Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study |
title_full | Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study |
title_fullStr | Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study |
title_full_unstemmed | Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study |
title_short | Patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study |
title_sort | patients’ perspectives of tuberculosis treatment challenges and barriers to treatment adherence in ukraine: a qualitative study |
topic | Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044979/ https://www.ncbi.nlm.nih.gov/pubmed/32014870 http://dx.doi.org/10.1136/bmjopen-2019-032027 |
work_keys_str_mv | AT aibanaomowunmi patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT dauriaemily patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT kiriazovatetiana patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT makarenkoolena patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT bachmahamariya patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT rybaknatasha patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT flanigantimothypalen patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT petrenkovasyl patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT beckerannee patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy AT murraymeganb patientsperspectivesoftuberculosistreatmentchallengesandbarrierstotreatmentadherenceinukraineaqualitativestudy |